Chakraborty Sandipan
Amity Institute of Biotechnology, Amity University, Kolkata 700135, India.
Int Immunopharmacol. 2022 Jan;102:108424. doi: 10.1016/j.intimp.2021.108424. Epub 2021 Dec 3.
SARS-CoV2 mutants B.1.1.7, B.1.351, and P.1 contain a key mutation N501Y. B.1.135 and P.1 lineages have another mutation, E484K. Here, we decode the effect of these two mutations on the host receptor, ACE2, and neutralizing antibody (B38) recognition. The N501Y RBD mutant binds to ACE2 with higher affinity due to improved π-π stacking and π-cation interactions. The higher binding affinity of the E484K mutant is caused due to the formation of additional hydrogen bond and salt-bridge interactions with ACE2. Both the mutants bind to the B38 antibody with reduced affinity due to the loss of several hydrogen-bonding interactions. The insights obtained from the study are crucial to interpret the increased transmissibility and reduced neutralization efficacy of rapidly emerging SARS-CoV2 VOCs.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变体B.1.1.7、B.1.351和P.1含有关键突变N501Y。B.1.135和P.1谱系还有另一个突变E484K。在此,我们解析这两个突变对宿主受体血管紧张素转换酶2(ACE2)以及中和抗体(B38)识别的影响。N501Y RBD突变体由于改善了π-π堆积和π-阳离子相互作用,以更高的亲和力与ACE2结合。E484K突变体较高的结合亲和力是由于与ACE2形成了额外的氢键和盐桥相互作用。由于若干氢键相互作用的丧失,这两种突变体均以降低的亲和力与B38抗体结合。该研究获得的见解对于解释快速出现的SARS-CoV-2变异株增加的传播性和降低的中和效力至关重要。